Hospital Clínico San Carlos de Madrid -ko ikertzaileekin lankidetzan egindako argitalpenak (11)

2024

  1. Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle

    Cancer Letters, Vol. 585

  2. POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated Rac1

    Molecular Oncology, Vol. 18, Núm. 3, pp. 620-640

  3. Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies

    Cell Communication and Signaling, Vol. 22, Núm. 1

2023

  1. Mapping Immune Correlates and Surfaceome Genes in BRAF Mutated Colorectal Cancers

    Current Oncology, Vol. 30, Núm. 3, pp. 2569-2581

  2. Pseudokinases, Tribbles Proteins and Cancer

    Cancers

2022

  1. Transcriptomic Mapping of Non-Small Cell Lung Cancer K-RAS p.G12C Mutated Tumors: Identification of Surfaceome Targets and Immunologic Correlates

    Frontiers in Immunology, Vol. 12

2021

  1. The pseudokinase TRIB3 negatively regulates the HER2 receptor pathway and is a biomarker of good prognosis in luminal breast cancer

    Cancers, Vol. 13, Núm. 21

2012

  1. Towards the use of cannabinoids as antitumour agents

    Nature Reviews Cancer, Vol. 12, Núm. 6, pp. 436-444

2011

  1. A combined preclinical therapy of cannabinoids and temozolomide against glioma

    Molecular Cancer Therapeutics, Vol. 10, Núm. 1, pp. 90-103

  2. Stimulation of ALK by the growth factor midkine renders glioma cells resistant to autophagy-mediated cell death

    Autophagy, Vol. 7, Núm. 9, pp. 1071-1073

  3. Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action

    Cell Death and Differentiation, Vol. 18, Núm. 6, pp. 959-973